医薬品市場調査

健康とウェルネスは人生において重要な部分です。

These sectors relate to the development, manufacture, and marketing of medicines. The global revenue of the pharmaceutical industry is more than $1 trillion. Almost half of this figure comes from two countries: the US and Canada. It is by far the most profitable industry of all. The primary and generic pharmaceutical companies lead the way in the industry.

業界の画期的な進歩のいくつかは、専門医薬品会社から生まれています。これらの会社の中には、大企業の 1 つの部門よりも従業員数が少ない会社もあります。これらの小規模な組織は、患者に多大な影響を与えています。これらの会社は、治療領域とニッチ市場に集中しています。これらの会社は、ターゲットを絞ったアプローチが結果をもたらす方法を示しています。一部の会社は、完全に 1 つの病気に焦点を当てています。他の会社は、人口の少数派にのみ影響する病気を治療しています。

The US pharmaceutical market dominates the rest of the world. The US is an innovator and a booster in the field of medical research and development. Their R&D benefits the international pharmaceutical industry. Still, one of the top conditions affecting US patients is diabetes. Oncology and autoimmune diseases are also the focus of much research in the US. Pfizer, Johnson & Johnson, and Merck & Co. are the largest companies on the US market.

医薬品市場の動向

Public Relations (PR) and Advertising are powerful for Pharma companies. One of the most prominent is the consumer as customer. Biotech stories are starting to proliferate. One such story involves the use of gene therapy to regrow the skin of a little boy. As drugs get personalized, stories such as these are capturing imaginations. They are also piquing people’s interest in the sector.

Patient stories can be powerful. Negative publicity can also be influential. One pharma company made headline news for charging $1,000 per day to treat hepatitis, creating a slew of negative publicity. It’s a brave – and complex new world for biotech and pharmaceutical companies.

There are several challenges in the pharmaceutical industry. These include policy reforms. For example, healthcare officials are likely to overhaul the Affordable Care Act soon. Another problem is the impact of new technologies. Industry players are still doubtful about the effects of these technologies. It is unclear how they will affect drug development and commercialization. Gene therapy and Gene editing are also gaining more headlines on opportunities and challenges in those sectors.

グローバル製薬業界のチャンス

Pharmaceutical sales are the largest in the US and Europe. Developed markets for pharmaceuticals comprise the United States and Western ヨーロッパ. Canada, Japan, and Australia are also part of this market. The United States sells approximately 33%, Western Europe, 22%, and China, 10%. Japan accounts for 9% Latin America, 7%, and Russia, 4%. South Korea, India, Indonesia, and Australia are below 3%.

製薬インフルエンサーマーケティング

One of the digital trends in pharma is influencer marketing. An influencer is one who is active in one or more of the social channels, with a large follower base. Pharma companies have been using influencers. These influencers have been reporting on their use of certain drugs and devices. They are also influencing people’s behavior in the area of disease prevention. Influencers can also encourage adherence to treatment protocols. Support groups can be highly influential in treatment and patient behavior.

高齢化社会

製薬業界の成長の原動力の 1 つは、米国およびほとんどの先進国における人口の高齢化です。もう 1 つの成長要因は、不健康なライフスタイルを送る人々の増加です。これらの悪い選択には、毎日の運動不足や不健康な食習慣が含まれます。

The USA and Europe are leaders in pharmaceutical development and use. Other areas like India and China have seen growth in recent years in the life science markets. The cause of this growth is an increasing demand for devices and products. It is also because of substantial capital opportunities.